Costochondritis and drugs of ingredients of prednisone - a phase IV clinical study of FDA data
Costochondritis is found among people who take drugs with ingredients of prednisone, especially for people who are female, 40-49 old , have been taking the drugs for 10+ years. This phase IV clinical study is created by eHealthMe based on reports of 477,825 people who have side effects when taking drugs with ingredients of prednisone from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Cortan, Delta-dome, Deltasone, Fernisone, Liquid pred, Meticorten, Orasone, Paracort, Prednicen-m, Prednisone, Prednisone intensol, Rayos, Servisone.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
477,825 people reported to have side effects when taking drugs with ingredients of prednisone.
Among them, 211 people (0.04%) have Costochondritis
What is Costochondritis?
Costochondritis (chest wall pain) is found to be associated with 951 drugs and 532 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of prednisone when people have Costochondritis *:
- < 1 month: 25.0 %
- 1 - 6 months: 25.0 %
- 6 - 12 months: 8.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 41.67 %
Gender of people who have Costochondritis when taking drugs with ingredients of prednisone *:
- female: 72.14 %
- male: 27.86 %
Age of people who have Costochondritis when taking drugs with ingredients of prednisone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.5 %
- 20-29: 3.75 %
- 30-39: 13.75 %
- 40-49: 30.0 %
- 50-59: 23.75 %
- 60+: 26.25 %
Conditions people have *:
- Pain: 33 people, 15.64%
- Multiple Myeloma (cancer of the plasma cells): 25 people, 11.85%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 24 people, 11.37%
- Osteoporosis (bones weak and more likely to break): 22 people, 10.43%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 18 people, 8.53%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 17 people, 8.06%
- Depression: 13 people, 6.16%
- Muscle Spasms (muscle contraction): 12 people, 5.69%
- Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 11 people, 5.21%
- Upper Respiratory Tract Infection: 11 people, 5.21%
Other drugs people take *:
- Ambien: 42 people, 19.91%
- Plaquenil: 37 people, 17.54%
- Ativan: 37 people, 17.54%
- Celebrex: 36 people, 17.06%
- Aredia: 36 people, 17.06%
- Zometa: 36 people, 17.06%
- Coumadin: 33 people, 15.64%
- Prevacid: 33 people, 15.64%
- Fosamax: 32 people, 15.17%
- Prilosec: 32 people, 15.17%
Other side effects people have besides Costochondritis *:
- Pain: 84 people, 39.81%
- Headache (pain in head): 75 people, 35.55%
- Joint Pain: 67 people, 31.75%
- Fatigue (feeling of tiredness): 67 people, 31.75%
- Cough: 66 people, 31.28%
- Stress And Anxiety: 65 people, 30.81%
- Nausea (feeling of having an urge to vomit): 62 people, 29.38%
- Chest Pain: 61 people, 28.91%
- Breathing Difficulty: 58 people, 27.49%
- High Blood Pressure: 55 people, 26.07%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of prednisone, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on prednisone. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Magnesium and Cyst - 9 seconds ago
- How effective is Norco for Migraine With Aura? - 10 seconds ago
- Epinephrine and Bumetanide drug interaction - 28 seconds ago
- Brukinsa and Rashes - 28 seconds ago
- Juvenile Rheumatoid Arthritis and Cardio-Respiratory Arrest - 34 seconds ago